Aramark grows its healthcare business

Aramark, the $15 billion provider of services in food, facilities management and uniforms, is growing its healthcare sector, with two new contracts with Kennedy Health in New Jersey and Vanderbilt University Medical Center in Tennessee, and expanded relationships two existing partners, Thomas Jefferson University Health System and the Einstein Healthcare Network, both in the Philadelphia area.

A new contract with 607-bed Kennedy Health means Aramark will provide both patient and retail food service at three Kennedy Health locations. Kennedy will transition the locations to Aramark’s room service model, which enables patients to call in cooked-to-order foods from a full menu at any time throughout the day. 

Aramark also entered into a new agreement to deliver a comprehensive healthcare technology management program involving biomedical, laboratory and diagnostic imaging equipment at Vanderbilt in Nashville. 

Aramark will expand its services with 951-bed Thomas Jefferson University Health System, its longest running healthcare client, where it has operated since 1955. The new work scope includes environmental services, patient transportation, patient food and linen distribution services.

Aramark added clinical technology management to its contract with 1,200-bed Einstein Healthcare Network. That includes biomedical engineering and diagnostic imaging at three locations. Aramark also has introduced its new Vibe Micromarkets at Einstein, providing employees and visitors with "grab and go" food items at any time of day or night. The company has provided patient and retail food service for Einstein Healthcare Network since 2009.

Aramark’s healthcare sector employs or manages more than 50,000 people serving more than 1,100 healthcare organizations across North America.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.